$RKLB

Rocket Lab stock tumbles as effort to take market share from SpaceX slips to 2027

Rocket Lab (RKLB) shares fell over 10% after the company delayed the first launch of its Neutron rocket to 2027, citing manufacturing issues. CEO Peter Beck attributed the delay to ensuring system margins. Neutron is key to Rocket Lab's competition with SpaceX (SPCX) in the medium-lift rocket market. The stock has dropped around 25% this year and 65% from its 52-week high. Cantor Fitzgerald maintained an Overweight rating and $122 price target.

Original reporting
Published Oct 15, 2026, 4:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 4:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rocket Lab stock tumbles as effort to take market share from SpaceX slips to 2027 — source image
Decision brief

The 30-second read

$RKLBBearishMed
01

Why it matters

The disclosed slip to 2027 is a direct execution-risk update for Rocket Lab’s reusable medium-lift program, driving a sharp same-day equity reaction and likely increasing the market’s required confidence level for future launch-date guidance.

02

Market read

A concrete schedule slip for Neutron’s debut is the catalyst, with the stock already down sharply year-to-date and the update released late in the trading day.

03

What to watch

The article notes strong demand and upcoming contract announcements, plus an ongoing Iridium deal effort, which could partially offset timeline disappointment if new contract details land soon.

Relevance 8/10Novelty 7/10Timing: after-hours update at 4:40 p.m. ET, with the selloff carrying into Thursday’s close

Background

Rocket Lab has repeatedly moved Neutron’s first-flight target since unveiling the rocket in 2021, and a first-stage tank ruptured during testing in January.

Company-level read

Ticker impact

$RKLBBearishHigh confidence
Context

Rocket Lab shares fell more than 10% after it said Neutron’s first launch slipped to 2027 due to manufacturing issues in the forward propellant dome.

Expected impact

Likely continued downside pressure as investors reprice Neutron schedule risk and demand more evidence of manufacturing fixes before new launch-date commitments.

Evidence & confidence

The article attributes the stock drop to a specific, company-confirmed schedule slip (2026 target to 2027) tied to identifiable manufacturing problems, with no new launch date provided yet.

Market effects

Highlights execution and manufacturing bottlenecks in reusable medium-lift development, which can weigh on sentiment across space launch names.

Primarily US-listed space sector sentiment, with spillover to other launch and satellite communications equities.

Limited direct global macro linkage, but reinforces global investor focus on launch cadence and reusability timelines.

Counterpoint

The company says it has identified manufacturing fixes and expects to finish assembling the first stage within the quarter, so the 2027 slip may be a manageable delay rather than a fundamental setback.

Key entities

  • Rocket Lab

    US-listed space company whose Neutron reusable medium-lift rocket first launch slipped to 2027, triggering a >10% stock drop.

  • Neutron

    Rocket Lab’s reusable medium-lift rocket, central to competing for larger missions versus SpaceX.

  • SpaceX

    Dominant launch provider referenced as the competitive benchmark for Neutron’s market-share goal.

  • Iridium

    Satellite operator Rocket Lab is working to close a deal with, per the article.

Related articles

$RKLBMed

Rocket Lab (RKLB) Delays Neutron Launch to 2027, Raising Executi

Rocket Lab (RKLB) delayed its Neutron rocket's first launch to 2027 from Q4 2026 due to manufacturing issues. The delay stems from problems with the rocket's propellant tank, requiring further testing and modifications. Neutron is key to Rocket Lab's strategy for larger missions and reusability, but repeated delays raise concerns about execution and growth timelines.

$RKLBMed

Rocket Lab Delays First Launch of New Rocket

Rocket Lab delayed the first launch of its Neutron rocket to 2027 due to carbon composite manufacturing issues, according to CEO Peter Beck. The company's shares fell 11% following the announcement and were down 9% to $53.86, giving it a market cap of $32 billion.

$RKLBMedAI 8/10

Rocket Lab Delays Neutron Rocket Launch to 2027, Stock Plummets

Rocket Lab Corp (RKLB) delayed its Neutron rocket launch to 2027 due to manufacturing issues, causing its stock to drop 14%. The company's P/S ratio is 18.9x, higher than historical levels, and insiders sold $26.96M in shares recently. RKLB has a GF Score of 77/100, with strong growth but weak profitability. The delay raises concerns about its operational efficiency and future growth prospects.

$RKLBMed

Why Rocket Lab (RKLB) Shares Are Sliding Today

Rocket Lab (RKLB) shares fell 9.8% after announcing a delay in the Neutron launch vehicle's inaugural launch to 2027 due to development and manufacturing issues. The Neutron rocket is key for expanding beyond small-satellite operations. The stock has seen significant volatility, down 29.9% year-to-date and 64.6% from its 52-week high.

$RKLBHigh

Rocket Lab Stock Sinks After New Neutron Launch Delay

Rocket Lab's shares dropped 12% after delaying Neutron rocket's first flight to 2027 due to manufacturing issues. The company discovered air pockets in a component and is building a replacement. Testing and assembly are expected to finish in Q1 2027. Management cited strong customer demand and potential new contracts.

$RKLBHigh

Rocket Lab Stock Falls After Neutron Launch Is Delayed Into 2027

Rocket Lab (RKLB) shares dropped 7.9% during trading and 7.3% after-hours after the company delayed the Neutron rocket's maiden flight to 2027. The delay was due to manufacturing defects in a carbon-composite tank component, requiring rework and new production. Neutron is key to competing with SpaceX, and delays increase development costs while pushing back revenue.